Pharmaceutical composition

JP2026094502APending Publication Date: 2026-06-09TAISHO PHARMACEUTICAL CO LTD
View PDF 5 Cites 0 Cited by

Patent Information

Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
TAISHO PHARMACEUTICAL CO LTD
Filing Date
2026-03-25
Publication Date
2026-06-09

AI Technical Summary

Benefits of technology

【0016】 本発明により、アンブロキソール又はその塩とキキョウを配合し、アンブロキソール又 はその塩の含量低下を抑制した優れた医薬組成物の提供が可能となった。

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2026094502000001
    Figure 2026094502000001
  • Figure 2026094502000002
    Figure 2026094502000002
Patent Text Reader

Abstract

In a solid preparation containing ambroxol or a salt thereof and balloon flower, ambroxol To provide an excellent solid formulation that suppresses the decrease in the content of ru or its salt. [Solution] A pharmaceutical composition characterized by containing at least one selected from the group consisting of (a) ambroxol or a salt thereof, (b) Platycodon grandiflorus, (c) dextromethorphan and a salt thereof, phenylephrine and a salt thereof, isopropamide iodide, and methoxyphenamine and a salt thereof, and ephedrines.
Need to check novelty before this filing date? Find Prior Art

Claims

1. A pharmaceutical composition characterized by containing at least one selected from the group consisting of (a) ambroxol or a salt thereof, (b) balloon flower, (c) dextromethorphan and a salt thereof, phenylephrine and a salt thereof, isopropamide iodide, methoxyphenamine and a salt thereof, and ephedrines.

2. (a) The medical device according to claim 1, wherein ambroxol or a salt thereof is ambroxol hydrochloride. A pharmaceutical composition.

3. (c) Claim that the salt of dextromethorphan is dextromethorphan hydrobromide. The pharmaceutical composition described in 1.

4. (c) The pharmaceutical composition according to claim 1, wherein the salt of phenylephrine is phenylephrine hydrochloride.

5. (c) The pharmaceutical product according to claim 1, wherein the salt of methoxyphenamine is methoxyphenamine hydrochloride. composition.

6. (c) Ephedrines include pseudoephedrine, norephedrine, and methylephedrine. The pharmaceutical composition according to claim 1, wherein it is at least one selected from the group consisting of dorin.

7. Any of claims 1 to 6, wherein the dosage form is a tablet, powder, fine granules, granules, pill, or capsule. A pharmaceutical composition as described below.